Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives.

: Two hundred and three children and siblings of patients with Alzheimer's disease (AD) (age range: 30-92 years, 75% female) were surveyed regarding potential predictive testing options for the disorder. A mailed questionnaire posed various hypothetical scenarios and assessed the following variables: interest in testing, perceptions of its pros and cons, and psychological and demographic predictors of test intentions. In 5 of 6 scenarios, a majority of participants expressed intentions to pursue testing, with perceived pros outweighing cons. The most important reasons for seeking testing were informing later-life decisions and planning future AD care. Predictors of test intentions were male gender, information-seeking style, higher perceived AD threat, and appraisal of test pros versus cons. Situational factors such as available treatment options and certainty of test information also affected responses. Results suggest a positive view of predictive testing, with its limitations and risks underrated. Study findings may inform AD genetic counseling and health education efforts.

[1]  Kenneth A. Wallston,et al.  Development of the Multidimensional Health Locus of Control (MHLC) Scales , 1978, Health education monographs.

[2]  A. Roses,et al.  The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. , 1997, JAMA.

[3]  A. Baum,et al.  Stress and genetic testing for disease risk. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[4]  A. Roses Genetic testing for Alzheimer disease. Practical and ethical issues. , 1997, Archives of neurology.

[5]  A. Goate,et al.  Exploring the etiology of Alzheimer disease using molecular genetics. , 1997, JAMA.

[6]  K. Davis,et al.  Patterns of risk in first-degree relatives of patients with Alzheimer's disease. , 1994, Archives of general psychiatry.

[7]  Kenneth Offit,et al.  Decision-Making About Genetic Testing Among Women at Familial Risk for Breast Cancer , 1997, Psychosomatic medicine.

[8]  Yael Benyamini,et al.  Illness representations: Theoretical foundations. , 1997 .

[9]  R. Croyle,et al.  The new genetics: Psychological responses to genetic testing , 1998 .

[10]  H. Neighbors,et al.  Towards a culturally competent system of care. , 2002 .

[11]  N. Holtzman,et al.  Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. , 1994, American journal of human genetics.

[12]  J. Growdon,et al.  Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study , 1996, Neurology.

[13]  R. Roos,et al.  Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. , 1994, American journal of human genetics.

[14]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[15]  A. Wexler Mapping fate : a memoir of family, risk, and genetic research , 1995 .

[16]  S. Folkman,et al.  Stress, appraisal, and coping , 1974 .

[17]  M. A. Safer,et al.  The Impact of Communications on the Self-Regulation of Health Beliefs, Decisions, and Behavior , 1983, Health education quarterly.

[18]  C. Lerman,et al.  Interest in genetic testing among first-degree relatives of breast cancer patients. , 1995, American journal of medical genetics.

[19]  B. Trock,et al.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.

[20]  T. Marteau,et al.  Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[21]  J. Coyne Stress and Coping in Genetic Testing for Cancer Risk , 1997 .

[22]  M. Schwartz,et al.  The influence of psychological distress on use of genetic testing for cancer risk , 1997 .

[23]  P. Rabins,et al.  Caregivers for dementia patients: a comparison of husbands and wives. , 1986, The Gerontologist.

[24]  G. Meissen,et al.  Intentions to use predictive testing by those at risk for Huntington's disease: Implications for prevention , 1988, American journal of community psychology.

[25]  W. Meschino,et al.  Molecular Genetic Predictive Testing for Alzheimer's Disease: Deliberations and Preliminary Recommendations , 1994, Alzheimer disease and associated disorders.

[26]  M. Morris,et al.  Reluctance to undergo predictive testing: the case of Huntington disease. , 1993, American journal of medical genetics.